Is your loved one diagnosed with classical homocystinuria?

Is your child (ages 5-11) living with classical HCU? Learn about our paid research study and explore the opportunity for your child to participate from the comfort of home.
Condition
Classical Homocystinuria
Study Treatment:
Investigational Drug
Age:
5-11
Sex:
All
Duration:
Up to 42 weeks; Up to 47 visits
Key Criteria:
Children diagnosed with Classical Homocystinuria
Location:
Remote (from your home)
- travel to a clinic for a DEXA scan or eye doctor will be required for some assessments.

Compensation
Up to $4,400 and paid based on study activities completed
Travel
None, participation is from home
Learn if your child may qualify for our paid classical HCU study.
Complete a short questionnaire.
Answer a few questions about your child's age and medical history to see if you pre-qualify for the study.
You'll receive an immediate response indicating whether your child pre-qualifies.
If your child pre-qualifies, learn about the next steps.
Our research team will guide you through the process, including requesting your child's medical records and discussing informed consent with you.
We'll make sure you understand what participation involves, your role as a parent or caregiver, and how the study works before deciding whether to move forward.
Explore the opportunity to participate from home. 
Our team will work with you to complete the next steps and determine whether your child is eligible to participate in the study.
See if Your Child Prequalifies
Don’t have Classical Homocystinuria but know someone who does?
Additional eligibility criteria apply.

What Is Being Studied and Why Might My Child Participate?

The COMPOSE study is evaluating pegtibatinase, an investigational drug that has not been approved by the FDA, in children ages 5 to 11 with classical homocystinuria (HCU). In HCU, a substance called homocysteine builds up in the blood. Pegtibatinase is designed to help prevent this buildup. Researchers want to learn how safe the study drug is in children, how well they tolerate it, and whether it affects homocysteine-related levels in the blood. This is the first time pegtibatinase is being given to children in this age group.

Every child receives the study drug; there is no placebo. Doses start low and may increase over 20 weeks, and the study doctor checks how your child is doing before each increase. Medicines often need to be studied specifically in children to understand safe and appropriate doses, and what researchers learn here will help determine whether pegtibatinase could be used to treat HCU in the future. Your child may or may not benefit directly.

This study is a real commitment: up to 42 weeks, with visits about twice a week during dosing. Science 37 makes that more manageable by bringing the study to you. For most visits, a nurse or healthcare professional comes to your home, and the study drug is delivered to your door. Clinic travel is needed only for an eye exam and a bone scan, if one is required.

Like all research, this study has possible risks, including injection-site and allergic reactions, which the study team will review with you in detail. Participation is voluntary, and you can withdraw your child at any time without affecting their regular care.

See If My Child Pre-Qualifies

Just two simple steps to see if your child may qualify.

Our dedicated team of patient experience coordinators is here to guide you through the initial steps and answer your questions along the way.

Complete a
Short Questionnaire

Answer a few quick questions about your child's age and medical history to see if they may pre-qualify for the study. You’ll receive an immediate response.

Sign a Medical Records
Release Form

If your child pre-qualifies, you'll be asked to sign a Medical Records Release Form so our research team can request and review your child's medical history. A Clinical Research Coordinator will then contact you to discuss the study and the informed consent process.
See if Your Child Prequalifies

What’s Involved in the Study?

See below for a summary of the timing and key activities.
Before
Complete the
Pre-Screening
Questionnaire
Fill out and Sign the
Medical Record
Request Form
Science37
Reviews Your Child's 
Medical Records
During
Review and Sign
the Informed Consent
Form with our Team
Complete Treatment 
Study Visits From Home
Complete Study Visits 
by Video Call From Home
Some Assessments May Require a DEXA Scan or Eye Exam
Compensation May 
Be Available
After
Safety follow-up: 
up to 4 weeks
Compensation May 
Be Available.
Don’t have Classical Homocystinuria but know someone who does?
See If Your Child Prequalifies
Don’t have for narcolepsy but know someone who does?
Additional eligibility criteria apply.
Additional eligibility criteria apply.

Have Questions?

We have an awesome team of doctors, researchers, and patient experience coordinators who are eager to help guide you through the research process.

Frequently Asked Questions

(323) 815-7790

travere_harmony_PEC@science37.com

Frequently Asked Questions (FAQ)

What does a typical research study look like?

There are different types of research studies, including those that are observational, where no investigational drug is given to the patient, and interventional, where an investigational drug/device/procedure is used. The government has established many rules to help ensure that research studies are conducted in the most ethical and safe way possible and that participants are protected throughout.

Why volunteer to take part in a research study?

Volunteers are part of the next wave of science and can influence the future of medicine. Advances in research have allowed people to get new treatments, new diagnostic tests, new procedures, etc. — and these breakthroughs wouldn’t be possible without volunteers.

Can I tell my doctor? Will my doctor get involved?

You can always share information about the research study with your primary doctor or healthcare provider. We encourage you to do so, especially if this is someone you know well and trust. Your doctor can be an additional resource when you are first learning about a research study and have any questions. You can continue to see your doctor throughout the research study for routine visits and tests. Our study team is available to talk to both you and your doctor if there are any concerns or questions. Working together helps to ensure that other medications or treatments you receive will not be a problem with the research study protocol. However, because these studies are investigational, the result of the study will not be available to individual patients.

Will taking part in a research study cost me anything?

There is no cost to participate, and many research studies offer reimbursement for your time and effort. Compensation depends on the research study and is discussed during the informed consent process.

How long is a research study?

Research studies are designed by a team of expert scientists, physicians, and statisticians. The duration of a research study varies depending on the protocol that this team develops. When you learn about a research study, you will be informed about the time commitment needed before you agree to participate.

Can I talk to other people about the research study?

Besides talking to the study staff, you should minimize sharing your experience in the research study with others. We understand that talking about your experience is an important part of feeling supported, but we ask that you not share information about the research study on social media or with other research study participants. This helps to ensure the most valid and highest-quality scientific results. Our study team is always available to address your questions and concerns.

What if I want to leave a research study?

You can leave the research study at any time and for any reason. You are under no obligation to complete a research study or give a reason why you’re leaving one. Although we do our best to make our research studies as easy as possible for you to take part in, we understand that there are many reasons why finishing may not be possible.

What happens to me after I complete the research study?

After you complete the research study, the study team will talk with you to answer your questions and get your feedback on your overall experience during the trial. As a Science 37 research study participant, you will have access to news and updates about medical discoveries, educational content, and future research opportunities. You will continue to see your local primary doctor or healthcare provider for routine medical care.
© 2026 Science 37 | All Rights Reserved